Cardiff Oncology
CRDF
CRDF
58 hedge funds and large institutions have $12.2M invested in Cardiff Oncology in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less capital invested
Capital invested by funds: $19.6M → $12.2M (-$7.44M)
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
58
Holding in Top 10
–
Calls
$302K
Puts
$255K
Top Buyers
| 1 | +$287K | |
| 2 | +$119K | |
| 3 | +$109K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$56.9K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$39K |
Top Sellers
| 1 | -$652K | |
| 2 | -$471K | |
| 3 | -$405K | |
| 4 |
Millennium Management
New York
|
-$299K |
| 5 |
Two Sigma Advisers
New York
|
-$213K |